help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Biophys J. BioFAST on March 11, 2005.
doi:10.1529/biophysj.104.050286
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
biophysj.104.050286v1
88/5/3072    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brigo, A.
Right arrow Articles by Briggs, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigo, A.
Right arrow Articles by Briggs, J. M.
Biophysical Journal 88:3072-3082 (2005)
© 2005 The Biophysical Society

Comparison of Multiple Molecular Dynamics Trajectories Calculated for the Drug-Resistant HIV-1 Integrase T66I/M154I Catalytic Domain

Alessandro Brigo *, Keun Woo Lee {dagger}, Gabriela Iurcu Mustata {dagger} and James M. Briggs {dagger}

* Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, 35131 Padova, Italy; and {dagger} Department of Biology and Biochemistry, University of Houston, Houston, Texas 77024-5001

Correspondence: Address reprint requests to James M. Briggs, Dept. of Biology and Biochemistry, University of Houston, Houston, TX 77204-5001. Tel.: 713-743-8366; Fax: 713-743-8351; E-mail: jbriggs{at}uh.edu.

HIV-1 integrase (IN) is an essential enzyme for the viral replication and an interesting target for the design of new pharmaceuticals for multidrug therapy of AIDS. Single and multiple mutations of IN at residues T66, S153, or M154 confer degrees of resistance to several inhibitors that prevent the enzyme from performing its normal strand transfer activity. Four different conformations of IN were chosen from a prior molecular dynamics (MD) simulation on the modeled IN T66I/M154I catalytic core domain as starting points for additional MD studies. The aim of this article is to understand the dynamic features that may play roles in the catalytic activity of the double mutant enzyme in the absence of any inhibitor. Moreover, we want to verify the influence of using different starting points on the MD trajectories and associated dynamical properties. By comparison of the trajectories obtained from these MD simulations we have demonstrated that the starting point does not affect the conformational space explored by this protein and that the time of the simulation is long enough to achieve convergence for this system.




This article has been cited by other articles:


Home page
Biophys. JHome page
C. N. Alves, S. Marti, R. Castillo, J. Andres, V. Moliner, I. Tunon, and E. Silla
A Quantum Mechanic/Molecular Mechanic Study of the Wild-Type and N155S Mutant HIV-1 Integrase Complexed with Diketo Acid
Biophys. J., April 1, 2008; 94(7): 2443 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
N. Nunthaboot, S. Pianwanit, V. Parasuk, J. O. Ebalunode, J. M. Briggs, and S. Kokpol
Hybrid Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulations of HIV-1 Integrase/Inhibitor Complexes
Biophys. J., November 15, 2007; 93(10): 3613 - 3626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Biophysical Society.